Effect of previous interferon treatment on the recurrence of hepatocellular carcinoma in patients with hepatitis C

被引:0
|
作者
Miyatake, Hirokazu
Kobayashi, Yoshiyuki
Iwasaki, Yoshiaki
Nakamura, Shinichirou
Tanaka, Hironori
Miyake, Yasuhiro
Terada, Ryo
Miyoshi, Kenji
Ohnishi, Hideki
Iwadou, Shouta
Shouji, Bon
Kuwaki, Takeshi
Sakaguchi, Kohsaku
Shiratori, Yasushi
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A497 / A497
页数:1
相关论文
共 50 条
  • [21] Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.
    Kasahara, A
    Hayashi, N
    Sasaki, Y
    Kakumu, S
    Kiyosawa, K
    Okita, K
    HEPATOLOGY, 2000, 32 (04) : 361A - 361A
  • [22] The effect of chemotherapy on hepatitis C recurrence in patients undergoing liver transplantation for hepatocellular carcinoma.
    Yeh, H
    Porrett, P
    Kaminski, M
    Sun, W
    Reddy, R
    Frank, A
    Korenda, K
    Olthoff, K
    Markmann, J
    Shaked, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 178 - 178
  • [23] Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C
    Yamanaka, Yutaka
    Shiraki, Katsuya
    Miyashita, Kazumi
    Inoue, Tomoko
    Kawakita, Tomoyuki
    Yamaguchi, Yumi
    Saitou, Yukiko
    Yamamoto, Norihiko
    Nakano, Takeshi
    Nakatsuka, Atsuhiro
    Yamakado, Koichiro
    Takeda, Kan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (14) : 2174 - 2178
  • [24] Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C
    Yutaka Yamanaka
    Katsuya Shiraki
    Kazumi Miyashita
    Tomoko Inoue
    Tomoyuki Kawakita
    Yumi Yamaguchi
    Yukiko Saitou
    Norihiko Yamamoto
    Takeshi Nakano
    Atsuhiro Nakatsuka
    Koichiro Yamakado
    Kan Takeda
    World Journal of Gastroenterology, 2005, (14) : 2174 - 2178
  • [25] Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study
    Suou, T
    Mitsuda, A
    Koda, M
    Matsuda, H
    Maruyama, S
    Tanaka, H
    Kishimoto, Y
    Michimori, K
    Hirooka, Y
    Kawasaki, H
    HEPATOLOGY RESEARCH, 2001, 20 (03) : 301 - 311
  • [26] The effect of interferon-free therapy on tumor recurrence in HCV patients with treatment history of hepatocellular carcinoma
    Tsuda, Yasuhiro
    Nishikawa, Tomohiro
    Nakamura, Ken
    Yokohama, Keisuke
    Ohama, Hideko
    Sujishil, Tetsuya
    Tsuchimoto, Yusuke
    Asai, Akira
    Fukunishi, Shinya
    Higuchi, Kazuhide
    HEPATOLOGY, 2016, 64 : 666A - 667A
  • [27] Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
    Sakae, Masayuki
    Kubo, Shoji
    Takemura, Shigekazu
    Sakata, Chikaharu
    Uenishi, Takahiro
    Kodai, Shintaro
    Shinkawa, Hiroji
    Urata, Yorihisa
    Ohata, Kazunori
    Kaneda, Kazuhisa
    Nishioka, Takayoshi
    Nozawa, Akinori
    Suehiro, Shigefumi
    HEPATOLOGY RESEARCH, 2012, 42 (06) : 564 - 573
  • [28] Preventive effect of interferon treatment on the incidence of hepatocellular carcinoma in chronic hepatitis C with advanced histological stages
    Imai, Y
    Kawata, S
    Tamura, S
    Yabuuchi, I
    Noda, S
    Inada, M
    Maeda, Y
    Shirai, Y
    Fukuzaki, T
    Kaji, I
    Ishikawa, H
    Matsuda, Y
    Matsuzawa, Y
    HEPATOLOGY, 1997, 26 (04) : 1141 - 1141
  • [29] Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
    Kasahara, A
    Hayashi, N
    Mochizuki, K
    Takayanagi, M
    Yoshioka, K
    Kakumu, S
    Iijima, A
    Urushihara, A
    Kiyosawa, K
    Okuda, M
    Hino, K
    Okita, K
    HEPATOLOGY, 1998, 27 (05) : 1394 - 1402
  • [30] Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
    Singal, Amit G.
    Marrero, Jorge A.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 832 - 834